Endogenous nitric oxide prevents myocardial ischemia in patients with hypertension and left ventricular hypertrophy

American Heart Journal

Volumn 143, Issue 4, 2002, Pages 684-689

  Mohri, Masahiro ^a   Ichiki, Toshihiro ^a   Hirooka, Yoshitaka ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; LACTIC ACID; N(G) METHYLARGININE; NITRIC OXIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL;

EID: 0036235249     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.120149     Document Type: Article

References (29)

1. Vasodilator reserve: A functional assessment of coronary health
2. Primary endothelial dysfunction: Atherosclerosis
3. Inhibition of nitric oxide production aggravates myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis
4. Role of nitric oxide in regulation of coronary blood flow during myocardial ischemia in dogs
5. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure
6. Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption
7. Improvement of coronary flow reserve after long-term therapy with enalapril
8. Coronary vascular adaptations to myocardial hypertrophy
9. Coronary pressure-flow relation in left ventricular hypertrophy. Importance of changes in back pressure versus changes in minimum resistance
10. Regional myocardial blood flow during exercise in dogs with chronic left ventricular hypertrophy
11. Abnormalities in myocardial perfusion during tachycardia in dogs with left ventricular hypertrophy: Metabolic evidence for myocardial ischemia
12. Role of endothelium-derived nitric oxide in coronary vasodilation induced by pacing tachycardia in humans
13. Bradykinin-induced vasodilation of human coronary arteries in vivo: Role of nitric oxide and angiotensin-converting enzyme
14. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans
15. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms
16. Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo
17. Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure
18. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method
19. Role of NO and K(+)(ATP) channels in adenosine-induced vasodilation on in vivo canine subendocardial arterioles
20. Mechanical transduction of nitric oxide synthesis in the beating heart
21. The nitric oxide donor ITF 1129 augments subendocardial blood flow during exercise-induced myocardial ischemia
22. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels
23. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension
24. Coronary microvascular disease in humans
25. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy
26. Tetrahydrobiopterin improves endothelial dysfunction in the coronary microcirculation in patients without epicardial coronary artery disease
27. Intracoronary enalaprilat improves metabolic coronary vasodilation in patients with idiopathic dilated cardiomyopathy
28. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction
29. Reduction of serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia